Patent Pre-Grant Opposition Strategy for India-Filed US Innovations

Pre-grant opposition is no longer the niche procedural instrument it once was. US innovators filing patents in India through the national-phase route should anticipate the possibility of pre-grant opposition as an integral part of their portfolio strategy, particularly in the pharmaceutical, agrochemical, and emerging technology sectors.

The strategic question is how to prepare the application itself to withstand opposition. Three practices have consistently improved outcomes for our LPO clients. First, the patent specification should anticipate the most likely lines of opposition and address them in the substantive description, rather than reserving the response for the opposition phase. Second, the claim architecture should be drafted with the Indian examiner's interpretive disposition in mind, which differs in subtle but meaningful ways from the USPTO posture. Third, the prior-art search performed before filing should be deliberately broader than the patentability search a US applicant might consider sufficient.

On the opposition side, our LPO bench supports US firms through both substantive preparation and procedural management. The preparation of expert affidavits, the construction of comparative claim charts, and the calibrated framing of inventive step arguments are all work products we routinely deliver inside the US firm's case-management workflow.

The Indian patent landscape rewards applicants who treat the application as a strategic document rather than a procedural one. US innovators who adapt their drafting and filing posture to that reality will find the Indian portfolio more durable.